Alerts will be sent to your verified email
Verify Email
LALPATHLAB
|
Dr. Lal Pathlabs
|
Vijaya Diagnostic
|
Thyrocare Tech.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Diagnostics
|
|||
|
Number of Diagnostic Centres
|
277.0 . | 121.0 . | n/a |
|
Realization/Patient - Diagnostic Centres
|
754.0 Rs/Patient | n/a | n/a |
|
Number of Daily Patients - Diagnostic Centres
|
74.44 Ths | n/a | 42.19 Ths |
|
Number of Samples - Quarterly
|
18.6 Million | n/a | 5.58 Million |
|
Financials
|
|||
|
5 yr Average ROE
|
20.73 % | 21.48 % | 23.13 % |
|
5yr average Equity Multiplier
|
1.34 | 1.65 | 1.36 |
|
5yr Average Asset Turnover Ratio
|
0.97 | 0.66 | 0.81 |
|
5yr Avg Net Profit Margin
|
16.07 % | 19.74 % | 21.31 % |
|
Price to Book
|
10.91 | 11.72 | 6.88 |
|
P/E
|
58.63 | 61.99 | 51.01 |
|
5yr Avg Cash Conversion Cycle
|
-101.91 Days | -142.8 Days | 34.58 Days |
|
Inventory Days
|
9.56 Days | 2.65 Days | 16.27 Days |
|
Days Receivable
|
14.14 Days | 7.65 Days | 61.79 Days |
|
Days Payable
|
85.69 Days | 156.34 Days | 42.25 Days |
|
5yr Average Interest Coverage Ratio
|
86.61 | 7.4 | 114.35 |
|
5yr Avg ROCE
|
27.96 % | 22.99 % | 30.71 % |
|
5yr Avg Operating Profit Margin
|
28.95 % | 44.18 % | 37.85 % |
|
5 yr average Debt to Equity
|
0.07 | 0.07 | 0.0 |
|
5yr CAGR Net Profit
|
3.7 % | 13.03 % | -5.02 % |
|
5yr Average Return on Assets
|
15.66 % | 13.14 % | 17.28 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.6 % | 54.06 % | 71.11 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 100.0 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.63 % | -0.72 % | 4.97 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.48 % | 13.48 % | 8.08 % |
|
Dr. Lal Pathlabs
|
Vijaya Diagnostic
|
Thyrocare Tech.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Distribution Channel
|
Distribution Channel
|
Distribution Channel
|
Distribution Channel
|
